Lupin to acquire Dutch ophthalmology firm VISUfarma
Enterprise value of the Amsterdam-based portfolio company of GHO Capital Partners offering a portfolio of 60 branded ophthalmology products pegged at euro 190 million
What's Your Reaction?

